The Canadian Cardiovascular Society Dyslipidemia Guidelines help Canadian physicians to diagnose and treat dyslipidemia (high lipid count) in patients and thereby help prevent cardiovascular disease. Below you will find a link to the CCS guidelines as well as our dyslipidemia guideline knowledge translation tools and resources; including smart phone apps, educational slide decks, pocket guides and more. Watch this page for announcements about educational webinars, workshops and accredited e-learning programs.
Dyslipidemia Guidelines App
Visit the CCS App page to view more CCS Apps
2012 CCS Dyslipidemia Guidelines Update English PPT
2012 CCS Dyslipidemia Guidelines Update French PPT
2012 CCS Dyslipidemia Guidelines Update (English Version)2012 CCS Dyslipidemia Guidelines Update (French Version)
CCC 2013 Guideline Workshops (Recordings)
Due to file size and connection speed, videos may take some time to load. Please note, these workshop recordings were recorded live during CCC at Vascular 2013.
Section 1 Accredited E-Learning Programs
Challenges of Lowering LDL-C: The Role of PCSK-9
Please note: You will be prompted to enter your email address and then your first and last name to download/stream the file.Canadian Cardiovascular Society Guidelines 2012 Update: Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult - Slide Deck
CCS is pleased to provide three highly engaging videos based on the 2009 Dyslipidemia Guidelines.
These videos address existing educational needs of health care professionals including primary care physicians, nurses and pharmacists as identified by a recent CCS needs assessment. Each video is 8-10 minutes and is designed to improve understanding of the 2009 Dyslipidemia Guidelines and put them into practice. Following each video, viewers will have an opportunity to test their knowledge and evaluate the video content.
Start watching now as a team of multidisciplinary cardiovascular health experts present on the following important topics.
Module 1 - Screening for CVD: The Importance of Family History
Module 2 - Risk Stratification and Treatment Target Selection
Module 3 - Strategies to Achieve Treatment Targets
It is Canadian Cardiovascular Society policy that no industry support is accepted for the development of guidelines or position statements.
The CCS accepts third party funding for guideline knowledge translation activities, seeking multiple supporters whenever possible. Support is accepted to offset the development and delivery costs of tools, resources, workshops and webinars. Supporters have no involvement in content development. Dyslipidemia Guideline knowledge translation is currently supported by: Merck, Amgen and Pfizer.
|Last Updated on Sunday, 16 February 2014|